Steroids Lab Pharmaceutical Company Ltd.
SARMs Supplement

SARMs Supplement SARMs Supplement

Sarms(Selective Androgen Receptor Modulators) is said to be the best choice of cycling steroids, it has great advantages of post cycle therapy too.we have all kinds of Sarms supplement in stock.

Sarms powder will greatly improve the body ability of building muscle, it links to the same receptors of traditional steroids, but it does not have the side effects of these steroids and prohormones, it is non-toxic, so it will not cause any damage to livers and for the most, it will raise your body level of estrogen. So there is no need for post cycle therapy after the usage of steroids, Although sarms are not legal for human body consumption, you can purchase from us without any concern. Sarms have little effect on blood pressure. Sarms have many of the benefits of traditional anabolics steroids without the side effects that with steroids. They can help you build muscle, burn fat and also improve the bone density.

Our sarms products include: MK-2866 (Ostarine, Enobosarm), GW501516 (GSK-516, Endurobol), MK-677 (Ibutamoren), LGD-4033, SR9009, SR9011, YK-11, RAD140.

There is the benefit of the sarms:

  • Increase muscle size and strength
  • Deductive evidence has proven a significant increase in muscle tissue hypertrophy (growth of muscle tissue). Inductive evidence suggests subjects will gain between 3 to 15 lbs of muscle tissue over the a 12 week period, subjects increased muscle strength 20x more than those in the placebo group.
  • Tissue selectivity
According to the Oxford Academic journal of Endocrinology, nonsteroidal SARMs have been designed to attach itself to area of the DNA responsible for skeletal muscle protein synthesis. Unlike other anabolic agents, non steroidal SARMs do not affect any other tissues in the body
  • Safety and tolerability
In the Oxford Journal of Gerontology Series A: Biological Sciences and Medical Sciences, the popular nonsteroidal SARM LGD 4033 (Ligandrol) has been recently studied for it’s effectiveness and safety in healthy young men. Results were favorable indicated by hormone and lipid levels returning to normal without the use of a post cycle therapy. No dangers were detected throughout the study.
  • MK-2866 (Ostarine,Enobosarm)

    Enobosarm, better known as as Ostarine or MK 2866, is a Selective Androgen Receptor Modulator (SARM) developed by GTx (GTx-024) to combat muscle wasting and osteoporosis. MK-2866 (Ostarine,Enobosarm)
  • GW501516 (GSK-516,Endurobol)

    GW501516 (also known as GW-501,516, GW1516, GSK-516 and on the black market as Endurobol) is a PPARδ receptor agonist that was invented in a collaboration between Ligand Pharmaceuticals and GlaxoSmithKline in the 1990s. GW501516 (GSK-516,Endurobol)
  • MK-677 (Ibutamoren )

    It has been shown to increase the secretion of several hormones including GH and insulin-like growth factor 1 (IGF-1) and produces sustained increases in the plasma levels of these hormones without affecting cortisol levels. MK-677 (Ibutamoren )
  • S4 (Andarine ,GTX-007)

    Andarine is an orally active partial agonist of the androgen receptor (AR). S4 (Andarine ,GTX-007)
  • LGD-4033

    Ligandrol or LGD-4033, is a selective androgen receptor modulator (SARM) discovered by Ligand Pharmaceuticals and currently under development by Viking Therapeutics. LGD-4033
  • SR9009

    Activation of Rev-erb-α by in mice SR9009 increases exercise capacity in mice by increasing mitochondria in skeletal muscle. SR9009
  • SR9011

    The compound SR9009 works by binding to one of the body’s naturally occurring molecules, called Rev-Erbα. SR9011
  • YK-11

    It is a gene-selective partial agonist of the androgen receptor (AR) and does not induce the physical interaction between the NTD/AF1 and LBD/AF2 (known as the N/C interaction), which is required for full transactivation of the AR. YK-11
  • RAD140

    RAD140 is an investigational selective androgen receptor modulator (SARM) for the treatment of conditions such as muscle wasting and breast cancer, currently under development by Radius Health, Inc. (RDUS). RAD140